Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2023-09-01
2024-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Weekly team exposure to training sessions and games will be collected as well as cases of groin problems in the entire population
When the season ends, the number of groin problems will be compared between teams that used the prevention program once a week against twice a week or no sessions a week.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adductor Strength in Roller Hockey Athletes
NCT05273008
Adductor Strength in Athletes Suffering a Groin Injury
NCT05554562
The Effectiveness of the Copenhagen Adduction Exercise on Soccer Players With Groin Pain or Injury
NCT05589623
Groin Injuries in Finnish Contact Sports
NCT02560480
Epidemiology of Roller Hockey Related Injuries.
NCT05006820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Teams will decide to implement the protocol once, twice or 0 times per week, depending on their schedule. No formal control group will be set, comparison of injuries will be performed between teams that used +80% of the total possible sessions and -80% (28 weeks equals a potential 42 CAE sessions throughout the season).
On a weekly basis, coaches will be contacted to report number of training sessions, games, and training sessions where they implemented CAE.
Bi-weekly, players will report any episode of groin problems (both leading to time-loss and those only affecting performance while not limiting participation).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Copenhagen Adduction Exercise Group
there is no control group, all teams can implement the intervention protocol that better fits their normal schedule, the intervention can consist of 1 or 2 Copenhagen Adduction Exercise sessions per week
Copenhagen Adduction Exercise
The CAE is performed by side-lying on the floor with the dominant lower limb supported in the air by a teammate, the hip is adducted until the body forms a straight line from the ankles to the shoulders (concentric phase), then the player is instructed to lower the body slowly (eccentric phase) until reaching the floor to start the next repetition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Copenhagen Adduction Exercise
The CAE is performed by side-lying on the floor with the dominant lower limb supported in the air by a teammate, the hip is adducted until the body forms a straight line from the ankles to the shoulders (concentric phase), then the player is instructed to lower the body slowly (eccentric phase) until reaching the floor to start the next repetition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 Accept participating in the study (signing the informed consent)
Exclusion Criteria
* 2 serious illness, injury or surgery in the previous 6 months that prevented rink hockey participation
16 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oviedo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hugo Olmedillas Fernandez
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hugo Olmedillas
Oviedo, Principality of Asturias, Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Previous research similar to this project
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UO2023/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.